Shinya� Fujita

A dose‐ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty

Takeshi Fuji, Shinya� Fujita, Shinya Tachibana et al. · Journal of Thrombosis and Haemostasis · 2010 · 137 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacology +14

Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, for Thromboprophylaxis After Total Hip Arthroplasty in Japan and Taiwan

Takeshi Fuji, C.-J. Wang, Shinya� Fujita et al. · The Journal of Arthroplasty · 2014 · 55 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?

Aya Nakaya, Shinya� Fujita, Atsushi� Satake et al. · Leukemia Research · 2016 · 49 citations

Pharmacy, Infectious Diseases, Oncology +16

Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era

Aya Nakaya, Shinya� Fujita, Atsushi� Satake et al. · Hematology Reports · 2017 · 36 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation

Shosaku� Nomura, Kazuyoshi� Ishii, Shinya� Fujita et al. · Transplant Immunology · 2017 · 30 citations · Full text

Life Sciences, Hematology, Immunology +13